Watershed moment for COPD research

A genome-wide association study of almost 50,000 people representing the extremes of  lung function has helped uncover 68 high priority genes as targets for future COPD drug development. The findings, published in Nature Genetics, also demonstrated the magnitude of the combined effect of genes on COPD susceptibility – with a 3.7 fold difference in COPD ...

Already a member?

Login to keep reading.

© 2021 the limbic